CS

Chanda Sridevi

Active Director Director DIN 06742169
DIN 06742169 First appointment Dec 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2013
Shareholding value •••• Premium profile

About Chanda Sridevi

Data last updated:

Chanda Sridevi is a Director at Lactonova Nutripharm Private Limited (since 2013). The company operates in Healthcare. Lactonova Nutripharm Private Limited reported revenue of ₹14.52 Cr (FY 2025).

DIN 06742169
Primary Designation Director
Industry Healthcare
First Appointment 23 Dec 2013
Oldest Company Age 12 yrs
Largest company Lactonova Nutripharm Private Limited · ₹14.52 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lactonova Nutripharm Private Limited U15490TG2013PTC091868
Director23 Dec 20132013₹14.52 Cr (FY 2025)Active

Board colleagues of Chanda Sridevi

Directorship timeline

Open interactive timeline →
Lactonova Nutripharm Private Limited
Premium access

Shareholding and investment profile for Chanda Sridevi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chanda Sridevi

Chanda Sridevi currently holds 1 directorship: Lactonova Nutripharm Private Limited (Director, since 23 Dec 2013, revenue ₹14.52 Cr (FY 2025)).

Chanda Sridevi was first appointed on 23 Dec 2013 as Director at Lactonova Nutripharm Private Limited.

The current boards of Chanda Sridevi's companies include Sampathkumar Chanda Janardhan (Lactonova Nutripharm Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available